Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
Posts published in “Tentative Approval”
Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
Asenapine maleate is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are three patents protecting this compound. Drug patent litigation for…
Tirofiban hydrochloride is the generic ingredient in one branded drug marketed by Medicure and is included in two NDAs. There is one patent protecting this compound. Drug patent litigation for…
[](//www.DrugPatentWatch.com/p/preview/generic-api/ticagrelor?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Ticagrelor is the generic ingredient in two branded drugs marketed by Astrazeneca Pharms, Amneal, Hisun Pharm Hangzhou, Sigmapharm Labs Llc, Sunshine, and Watson Labs Inc and, and is…
Tirofiban hydrochloride is the generic ingredient in one branded drug marketed by Medicure and is included in two NDAs. There is one patent protecting this compound. Drug patent litigation for…
